-
Management of atrial fibrillation with a rhythm-control strategy conferred no advantage over a rate-control strategy in cardiac or vascular mortality and may be associated with an increased noncardiovascular death rate.
-
A 12-month program of regular exercise in selected patients with chronic stable angina and significant CAD resulted in a higher event-free survival and exercise capacity at lower costs than PCI.
-
When administering the MMSE, use of serial 7s produces a more reliable score.
-
Most women with fibromyalgia have a variant of sleep apnea when carefully tested, and their symptoms improve with CPAP treatment.
-
The Dietary Approaches to Stop Hypertension diet, which suggests high intake of fruits, vegetables, and low-fat diary products, has been shown to favorably affect blood pressure in Stage 1 Hypertension as well as pre-hypertension.
-
The FDA has approved the combination of ezetimibe and simvastatin for the treatment of hypercholesterolemia. This combination product provides different mechanisms of action for lowering cholesterol.
-
Annual, or less frequent, surveillance intervals are effective for aneurysms < 45 mm in diameter.
-
Risk of Adenocarcinoma in Barretts Esophagus; Long-Term Effect of Doxazosin, Finasteride, and Combination for BPH; Once Daily Valacyclovir to Reduce Herpes Transmission; Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea; Association Between C-reactive Protein and Age-related Macular Degeneration; VZV Reactivation in Astronauts
-
The following summary of selected abstracts from 3 meetings will be published in multiple parts. The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) met in Chicago September 14-17, 2003. The Infectious Disease Society of America (IDSA) met in San Diego October 9-12, 2003. The American Society of Tropical Medicine and Hygiene met in Philadelphia December 3-7, 2003.
-
The 50-year-old drug colistin was used successfully in 14 of 23 cases of serious infections caused by multiply resistant Pseudomonas aeruginosa .
